Exposure to excessive natural heat

VWXY20_EXPOS_EXCESSI_NATURAL_HEAT

No definition available.

Endpoint definition

↥

Report an error or suggest an improvement for this endpoint codes

Endpoint definition steps	FinnGen
Phenotype data	520210
1. Apply sex-specific rule None	520210
2. Check conditions None	520210
3. Check pre-conditions, main-only, mode, registry filters Registry filters: Hospital discharge: ICD-10 — X30 Cause of death: ICD-10 — X30 2 out of 7 registries used, show all original rules.	77
4. Check minimum number of events None	77
5. Include endpoints None	77
6. Filter based on genotype QC (FinnGen only)	77

Control definitions (FinnGen only)

Controls for this endpoint are individuals that are not cases.

Extra metadata

Level in the ICD hierarchy: 5
First used in FinnGen datafreeze: DF4
Parent code in ICD-10: X30-X39

NAME	VWXY20_EXPOS_EXCESSI_NATURAL_HEAT
CONTROL_EXCLUDE
CONTROL_PRECONDITIONS
CONTROL_CONDITIONS
SEX
INCLUDE
PRE_CONDITIONS
CONDITIONS
OUTPAT_ICD
OUTPAT_OPER
HD_MAINONLY
HD_ICD_10_ATC
HD_ICD_10	X30
HD_ICD_9
HD_ICD_8
HD_ICD_10_EXCL
HD_ICD_9_EXCL
HD_ICD_8_EXCL
COD_MAINONLY
COD_ICD_10	X30
COD_ICD_9
COD_ICD_8
COD_ICD_10_EXCL
COD_ICD_9_EXCL
COD_ICD_8_EXCL
OPER_NOM
OPER_HL
OPER_HP1
OPER_HP2
KELA_REIMB
KELA_REIMB_ICD
KELA_ATC_NEEDOTHER
KELA_ATC
KELA_VNRO_NEEDOTHER
KELA_VNRO
CANC_TOPO
CANC_TOPO_EXCL
CANC_MORPH
CANC_MORPH_EXCL
CANC_BEHAV

Similar endpoints

↥

List of similar endpoints to Exposure to excessive natural heat based on the number of shared cases.

Similar with more cases:

Similar with less cases:

None

Case counts by codes

↥

FinnGen case counts by registry codes:

Upset plot

Full data table

Summary Statistics

↥

-FinRegistry-

This endpoint is excluded from FinRegistry analyses (omitted endpoint).

-FinnGen-

Key figures

	All	Female	Male
Number of individuals	77	38	39
Unadjusted period prevalence (%)	0.02	0.01	0.02
Median age at first event (years)	62.87	65.41	60.40

-FinnGen-

Age distribution of first events

-FinnGen-

Year distribution of first events

-FinnGen-

Cumulative Incidence Function

Not a core endpoint, no data to show.

CodeWAS (R11)

↥

CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.

This is a new tool, please reach out using the contact form for feedback and improvement ideas.

First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log₁₀(p-value) ≥ 6.

Matched cohort

Matched cases
68: Matched controls
682

Code

Vocabulary

Description

Odds Ratio

-log₁₀(p)

N matched cases

N matched controls

X30

ICD-10 Finland

Exposure to excessive natural heat

+∞

94.8

T67.0

ICD-10 Finland

Heatstroke and sunstroke

+∞

14.0

T67.3

ICD-10 Finland

Heat exhaustion, anhydrotic

+∞

9.6

F20.9

ICD-10 Finland

Schizophrenia, unspecified

28.8

7.8

N05AH02

ATC

clozapine; systemic

34.0

7.3

112

Kela drug reimbursment

Severe psychotic and other severe mental disorders

8.2

6.1

LabWAS

↥

N Cases

N Controls

-log₁₀(p)

cases

controls

cases

controls

unit

-log₁₀(p)

N cases

N controls

(3023368) Bacteria identified in Blood by Culture

171

4.67

10.32

5.6

4.7

—

(40762366) Oxygen capacity [Volume Fraction] in Arterial blood

5.81

6.48

7.4

8.2

—

(3002173) Hemoglobin [Mass/volume] in Arterial blood

4.34

6.36

7.3

7.9

120.42

121.83

g/l

0.10

(3026008) Bacteria identified in Urine by Culture

185

2.92

5.04

3.9

3.5

—

(3015399) Transferrin receptor.soluble [Mass/volume] in Serum or Plasma

150

2.94

4.87

2.4

2.0

2.90

3.19

mg/l

0.26

129

(3038288) Influenza virus B RNA [Presence] in Specimen by NAA with probe detection

3.25

4.41

2.1

1.8

—

(3043924) Respiratory syncytial virus RNA [Identifier] in Specimen by NAA with probe detection

3.08

3.91

2.1

1.8

—

(3044938) Influenza virus A RNA [Presence] in Specimen by NAA with probe detection

100

2.85

3.91

2.0

1.9

—

(3042936) Bacteria identified in Isolate by Culture

2.83

3.64

3.0

1.9

—

(3023520) Reticulocytes [#/volume] in Blood

3.27

3.60

3.1

3.2

57.53

70.52

e9/l

—

(3047181) Lactate [Moles/volume] in Blood

6.23

3.44

8.4

8.2

1.20

1.05

mmol/l

—

(3037467) Urinalysis macro (dipstick) panel - Urine

426

2.65

3.30

5.0

4.4

—

(3001079) Blood group antibody screen [Presence] in Serum or Plasma

265

2.17

2.80

4.8

4.2

—

(3052851) Hemolysis interference index of Serum or Plasma

4.57

2.76

2.8

3.0

—

(3039000) Anion gap in Blood

6.40

2.75

9.5

8.2

10.33

10.50

mmol/l

—

(3018572) Chloride [Moles/volume] in Blood

6.40

2.75

9.7

8.2

103.50

104.40

mmol/l

—

(3008909) Norovirus RNA [Presence] in Stool by NAA with probe detection

5.02

2.66

1.0

1.1

—

(3016293) Bicarbonate [Moles/volume] in Serum or Plasma

3.12

2.60

6.0

6.1

22.41

24.54

mmol/l

0.45

(3000991) Gas panel - Venous blood

2.73

2.54

9.1

7.1

—

(3029634) Reagin Ab [Titer] in Serum by VDRL

6.59

2.41

1.0

1.9

—

(3023081) Carboxyhemoglobin/Hemoglobin.total in Blood

3.76

2.34

7.6

4.7

1.94

1.43

—

(3007930) Methemoglobin/Hemoglobin.total in Blood

3.76

2.34

7.6

4.8

1.13

0.87

—

(3000494) Fungus identified in Specimen by Culture

2.41

2.34

1.1

1.3

—

(3006315) Basophils [#/volume] in Blood

297

2.01

2.33

7.0

6.1

0.04

e9/l

0.32

256

(3001604) Monocytes [#/volume] in Blood

297

2.01

2.33

7.0

6.1

0.57

0.61

e9/l

0.91

256

(3016431) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Serum or Plasma

299

1.99

2.26

9.3

6.3

1.18

1.21

mmol/l

2.16

238

(42870588) Differential panel, method unspecified - Blood

201

2.01

2.24

7.4

5.5

—

(36031861) Influenza virus A and B and SARS-CoV-2 (COVID-19) and Respiratory syncytial virus RNA panel - Respiratory system specimen by NAA with probe detection

3.26

2.23

2.0

1.7

—

(3046524) Influenza virus A Ag [Presence] in Nasopharynx by Immunoassay

3.94

2.21

2.0

1.5

—

(3043362) Influenza virus B Ag [Presence] in Nasopharynx by Immunoassay

3.94

2.21

2.0

1.5

—

(3019198) Lymphocytes [#/volume] in Blood

301

1.97

2.20

7.0

6.1

1.88

1.80

e9/l

0.26

267

(3013115) Eosinophils [#/volume] in Blood

303

1.95

2.14

10.1

6.5

0.16

0.18

e9/l

0.28

264

(3019539) Treponema pallidum Ab [Titer] in Serum by Hemagglutination

5.26

2.10

1.0

1.9

—

(3012544) pH of Venous blood

2.41

2.03

6.4

4.4

—

(3012516) Albumin [Mass/volume] in Urine

150

1.99

1.95

3.1

3.5

73.88

83.58

mg/l

0.06

(3024561) Albumin [Mass/volume] in Serum or Plasma

263

1.88

1.94

5.2

5.0

33.28

35.52

g/l

1.52

245

(3024891) Influenza virus A+B Ag [Presence] in Specimen

3.24

1.85

1.4

1.2

—

(3023103) Potassium [Moles/volume] in Serum or Plasma

614

2.54

1.82

29.4

17.6

4.02

4.00

mmol/l

0.21

596

(1761868) Lipid panel - Serum or Plasma

222

0.46

1.72

2.3

2.9

—

(3051552) Clostridioides difficile toxin genes [Presence] in Stool by NAA with probe detection

2.52

1.68

1.0

1.7

—

(3035995) Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma

474

1.91

1.62

7.7

7.9

82.36

78.29

u/l

0.22

441

(46237023) Hepatitis B virus core and surface Ab and surface Ag panel - Serum

2.86

1.62

1.0

1.1

—

(3019060) Gas panel - Arterial blood

2.46

1.61

7.2

4.6

—

(3020682) Albumin/Creatinine [Ratio] in Urine

162

1.80

1.51

3.1

4.5

6.87

11.88

mg/mmol

0.48

105

(3029187) Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Serum or Plasma

188

1.77

1.51

2.9

3.4

2894.59

2001.37

ng/l

0.21

154

(3018418) pH of Serum or Plasma

189

1.76

1.48

6.4

4.0

7.44

7.41

—

(43054903) Holo-transcobalamin II [Moles/volume] in Serum

234

1.72

1.46

2.6

2.0

91.33

88.47

pmol/l

0.10

115

(3019309) Folate [Moles/volume] in Red Blood Cells

130

1.85

1.46

1.7

882.38

1206.04

nmol/l

1.20

100

(3016251) Hemoglobin.gastrointestinal [Presence] in Stool

2.55

1.43

3.1

2.2

—

(3007853) Bacteria identified in Skin by Aerobe culture

2.03

1.41

2.4

1.6

—

(3027545) Mycoplasma pneumoniae Ab [Presence] in Serum by Immunoassay

3.07

1.38

1.4

1.5

—

(46235355) HIV 1 and 2 tests - Meaningful Use set

151

1.75

1.32

1.9

—

(3010521) Mycoplasma pneumoniae IgM Ab [Presence] in Serum by Immunoassay

2.90

1.30

1.0

1.1

—

(3026782) Osmolality of Urine

135

1.76

1.29

3.3

3.4

509.50

547.52

mosm/kgh2o

0.54

118

(3021879) Hepatitis B virus core Ab [Presence] in Serum

2.04

1.26

1.2

1.4

—

(3022250) Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma by Lactate to pyruvate reaction

1.92

1.23

5.6

3.7

252.36

233.75

u/l

0.13

(3046870) Tissue transglutaminase IgG Ab [Units/volume] in Serum

2.41

1.21

1.0

1.1

—

(3002032) Base excess in Venous blood by calculation

1.97

1.17

7.2

4.3

1.31

1.98

mmol/l

—

(3013650) Neutrophils [#/volume] in Blood by Automated count

363

1.58

1.12

28.4

9.6

4.50

4.30

e9/l

0.24

318

(3002582) Erythrocytes [#/volume] in Urine

213

1.58

1.07

4.3

3.7

40.98

32.96

e6/l

0.11

172

(3044640) Blood type and Crossmatch panel - Blood

187

1.59

1.04

2.1

2.3

—

(3019832) Treponema pallidum Ab [Presence] in Serum

1.83

1.03

1.3

1.7

—

(46236098) ABO and Rh group [Type] in Blood by Confirmatory method

136

1.64

1.00

1.9

2.1

—

(40761511) CBC panel - Blood by Automated count

642

1.99

0.99

24.6

13.7

—

(3029287) Urinalysis microscopic panel [#/volume] - Urine by Automated count

236

1.52

0.96

4.4

3.5

—

(3019800) Troponin T.cardiac [Mass/volume] in Serum or Plasma

256

1.51

0.93

3.4

4.2

21.41

48.87

ng/l

1.06

194

(3018006) Microscopic observation [Identifier] in Cervix by Cyto stain.thin prep

1.84

0.92

1.2

1.5

—

(36660697) Celiac disease serology panel - Serum

1.91

0.89

1.0

1.1

—

(36304419) Bacteria [Presence] in Urine

185

1.52

0.87

4.6

3.3

—

(3024135) Streptococcus.beta-hemolytic [Presence] in Throat by Organism specific culture

115

1.61

0.86

2.4

1.6

—

(3041096) Erythrocytes [Presence] in Urine by Automated

193

0.61

0.84

4.9

3.4

—

(3011397) Hemoglobin [Presence] in Urine by Test strip

142

1.55

0.83

3.3

—

(3003694) ABO and Rh group [Type] in Blood

160

1.52

0.83

1.3

1.5

—

(3032080) INR in Blood by Coagulation assay

252

1.46

0.82

10.0

8.8

1.36

1.21

inr

—

(43534045) MCM6 gene c.-13910C>T and -13915T>G [Identifier] in Blood or Tissue by Molecular genetics method Nominal

1.83

0.78

1.0

—

(3045414) Leukocytes [Presence] in Urine

2.25

0.77

3.0

1.7

—

(3019284) Hepatitis B virus surface Ag [Presence] in Serum

128

1.53

0.74

1.3

1.6

—

(3027944) Amphetamines [Presence] in Urine

1.91

0.70

6.6

1.4

—

(3018095) Leukocytes [#/volume] in Urine

241

1.40

0.67

5.1

4.2

225.57

68.49

e6/l

0.35

185

(3027008) Opiates [Presence] in Urine

1.84

0.67

6.6

1.5

—

(3000764) Benzodiazepines [Presence] in Urine

1.84

0.67

6.6

1.5

—

(40763086) Leukocyte esterase [Presence] in Urine by Automated test strip

258

0.70

0.65

4.7

3.7

—

(3028300) Cannabinoids [Presence] in Urine

1.77

0.65

6.6

1.5

—

(40758558) Short blood count panel - Blood

168

1.43

0.65

19.0

6.7

—

(3030467) Casts [#/volume] in Urine by Automated count

196

1.41

0.64

4.6

3.5

0.74

0.43

e6/l

0.22

154

(4010399)

1.63

0.63

1.4

1.2

—

(3011371) Neisseria gonorrhoeae DNA [Presence] in Specimen by NAA with probe detection

1.71

0.62

1.4

2.2

—

(1761482) Bacteria [#/volume] in Urine by Culture

0.00

0.61

0.0

6.7

—

(3009542) Hematocrit [Volume Fraction] of Blood

559

1.44

0.58

37.2

15.3

40.19

40.34

0.06

412

(3006093) Chlamydia trachomatis DNA [Presence] in Specimen by NAA with probe detection

1.67

0.57

1.5

2.4

—

(3009201) Thyrotropin [Units/volume] in Serum or Plasma

549

1.42

0.57

5.2

4.6

1.74

1.91

mu/l

0.76

501

(3029879) Epithelial cells.squamous [#/volume] in Urine by Automated count

109

1.47

0.56

4.3

3.3

6.89

0.99

e6/l

—

(3017143) Hepatitis C virus Ab [Presence] in Serum

103

1.44

0.49

1.3

1.5

—

(706163) SARS-CoV-2 (COVID-19) RNA [Presence] in Respiratory system specimen by NAA with probe detection

389

1.31

0.49

3.4

3.2

—

(3013603) Prostate specific Ag [Mass/volume] in Serum or Plasma

215

0.73

0.47

4.1

4.9

1.21

1.78

ug/l

0.62

189

(3020630) Protein [Mass/volume] in Serum or Plasma

1.47

0.47

2.4

2.9

62.33

66.38

g/l

—

(3018251) Fasting glucose [Moles/volume] in Serum or Plasma

566

1.37

0.47

5.3

4.3

5.99

5.92

mmol/l

0.15

511

(3017044) Thyrotropin receptor Ab [Units/volume] in Serum

0.00

0.41

0.0

2.3

—

3.83

—

(21492888) Glucose tolerance 2 hours gestational panel - Serum or Plasma

0.00

0.41

0.0

1.7

—

(3044889) 12 lead EKG panel

416

1.26

0.40

4.8

3.9

—

(3020321) Streptococcus agalactiae [Presence] in Vaginal fluid by Organism specific culture

0.00

0.39

0.0

1.4

—

(3003510) Neisseria gonorrhoeae DNA [Presence] in Urine by NAA with probe detection

1.42

0.39

2.7

2.0

—

(3024950) Chlamydia trachomatis DNA [Presence] in Urine by NAA with probe detection

1.34

0.32

3.8

2.2

—

(43054914) Glucose tolerance 2 hours panel - Serum or Plasma

1.35

0.32

1.7

1.9

—

(3030306) Epithelial cells.non-squamous [#/volume] in Urine by Automated count

121

1.30

0.31

4.2

2.9

0.79

0.97

e6/l

—

(3000492) Spirometry study

1.30

0.29

2.0

1.5

—

(3008486) Thyroxine (T4) free [Moles/volume] in Serum or Plasma

456

1.21

0.28

3.9

3.8

14.94

14.80

pmol/l

0.12

410

(3002256) Pathology report gross observation

1.24

0.28

1.4

1.3

—

(40764999) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)

583

1.22

0.23

20.0

14.5

79.45

81.09

ml/min/173m2

0.16

481

(3030981) Hyaline casts [#/volume] in Urine by Automated count

1.30

0.23

2.0

3.6

0.05

0.14

e6/l

—

(3015816) F5 gene p.Arg506Gln [Presence] in Blood or Tissue by Molecular genetics method

0.00

0.21

0.0

1.2

—

(3050238) Crystals [Presence] in Synovial fluid by Light microscopy

0.00

0.21

0.0

2.3

—

(3007844) Epstein Barr virus capsid IgM Ab [Units/volume] in Serum by Immunoassay

0.00

0.21

0.0

1.4

—

(40768793) Breast Pathology biopsy report

0.00

0.21

0.0

1.3

—

(3028531) Enolase.neuron specific [Mass/volume] in Serum or Plasma

0.00

0.21

0.0

1.7

—

15.73

—

(3033705) Calcium.ionized [Moles/volume] in Venous blood

0.00

0.21

0.0

2.0

—

(3041354) Potassium [Moles/volume] in Venous blood

0.00

0.21

0.0

2.0

—

4.08

—

(3012110) Lysozyme [Mass/volume] in Serum or Plasma

0.00

0.21

0.0

1.8

—

9.06

—

(3035285) Chloride [Moles/volume] in Venous blood

0.00

0.21

0.0

2.0

—

107.42

—

(3051387) C reactive protein [Mass/volume] in Capillary blood

0.00

0.20

0.0

4.6

—

22.80

—

(3013512) EKG study

176

1.18

0.20

4.4

4.2

—

(40768804) Tissue Pathology biopsy report

216

1.16

0.18

2.1

2.0

—

(3045783) Sodium and Potassium panel [Moles/volume] - Serum or Plasma

1.20

0.17

6.9

7.8

—

(3033319) Streptococcus pyogenes Ag [Presence] in Throat

1.20

0.17

2.1

1.5

—

(40768797) Stomach Pathology biopsy report

0.76

0.16

1.2

—

(3000067) Parathyrin.intact [Mass/volume] in Serum or Plasma

1.17

0.10

8.4

4.6

136.00

82.17

ng/l

—

(3022621) pH of Urine by Test strip

1.12

0.10

3.8

1.9

—

(3004588) Protein electrophoresis panel - Serum or Plasma

1.04

0.09

2.8

2.1

—

(3019225) pH of Specimen

1.12

0.09

2.2

3.4

—

(40761536) Microorganisms panel - Urine sediment

0.77

0.08

9.0

3.3

—

(3022145) Colonoscopy Study observation

1.12

0.08

1.1

1.4

—

(3016417) Amylase.pancreatic [Enzymatic activity/volume] in Serum or Plasma

1.08

0.08

1.9

2.0

28.00

30.19

u/l

—

(3019902) Methicillin resistant Staphylococcus aureus [Presence] in Specimen by Organism specific culture

1.06

0.07

2.8

4.0

—

(3029937) Albumin [Presence] in Urine by Test strip

182

0.92

0.06

5.5

3.6

0.00

estimate

—

(3007164) IgA [Mass/volume] in Serum or Plasma

139

1.10

0.06

1.1

1.3

2.71

2.35

g/l

—

(3035350) Ketones [Presence] in Urine by Test strip

322

0.94

0.05

4.4

3.6

0.00

estimate

—

(3009261) Glucose [Presence] in Urine by Test strip

327

0.96

0.01

4.4

3.6

0.00

estimate

—

(3015736) pH of Urine

248

1.01

0.00

4.7

3.6

—

(3021589) Normoblasts [#/volume] in Blood

295

1.03

0.00

17.7

10.1

0.00

e9/l

0.00

240

(40760892) CBC W Ordered Manual Differential panel - Blood

145

0.96

0.00

6.0

6.1

—

(3014702) Chromogranin A [Moles/volume] in Serum or Plasma

0.00

0.0

4.8

—

3.39

—

(3051611) Lipemic interference index of Serum or Plasma

0.00

0.0

2.3

—

(21494890) Protein electrophoresis panel - 24 hour Urine

0.00

0.0

1.3

—

(3032699) Streptococcus pneumoniae DNA [Presence] in Specimen by NAA with probe detection

0.00

0.0

1.6

—

(37020937) Giardia lamblia DNA [Presence] in Stool by NAA with probe detection

0.00

0.0

1.0

—

(3050380) Cytology report of Cervical or vaginal smear or scraping Cyto stain

0.00

0.0

1.5

—

(3042975) Streptococcus sp identified in Isolate by Organism specific culture

0.00

0.0

1.0

—

(3023419) Bacteria identified in Sputum by Culture

0.00

0.0

2.8

—

(36305771) Cryptosporidium sp DNA [Presence] in Stool by NAA with probe detection

0.00

0.0

1.0

—

(3030136) 5-Hydroxyindoleacetate [Moles/volume] in Serum or Plasma

0.00

0.0

4.6

—

75.00

—

(3047189) Immunofixation for 24 hour Urine

0.00

0.0

1.2

—

(3051651) Icteric interference index of Serum or Plasma

0.00

0.0

2.3

—

(3045156) Carbon dioxide [Partial pressure] adjusted to patient's actual temperature in Arterial blood

0.00

0.0

3.2

—

(3053028) Streptococcus sp identified in Specimen by Organism specific culture

0.00

0.0

1.2

—

(3018559) Microscopic observation [Identifier] in Buccal smear by Cyto stain

0.00

0.0

1.0

—

(3009595) Pneumocystis jiroveci DNA [Presence] in Specimen by NAA with probe detection

0.00

0.0

1.3

—

(3004451) EKG impression Narrative

0.00

0.0

1.4

—

(3044927) Protein electrophoresis panel - Urine

0.00

0.0

1.1

—

(3046896) Herpes virus 6 DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

0.00

0.0

1.2

—

(3048821) Cortisol [Moles/volume] in Serum or Plasma --post 1 mg dexamethasone PO overnight

0.00

0.0

1.7

—

(3022803) Oxygen [Partial pressure] adjusted to patient's actual temperature in Arterial blood

0.00

0.0

3.2

—

(4062490)

0.00

0.0

1.2

—

(3037875) Bordetella parapertussis DNA [Presence] in Specimen by NAA with probe detection

0.00

0.0

1.5

—

(3035637) Corticotropin [Mass/volume] in Plasma

0.00

0.0

1.2

—

(46235128) Lupus anticoagulant aPTT and dRVVT screening panel W Reflex

0.00

0.0

1.2

—

(3021125) Hepatitis C virus RNA [Presence] in Serum or Plasma by NAA with probe detection

0.00

0.0

2.0

—

(3044242) Glucose [Moles/volume] in Arterial blood

0.00

0.0

1.8

—

(40762119) U1 small nuclear ribonucleoprotein 70kD Ab [Units/volume] in Serum

0.00

0.0

1.0

—

(40768441) Liver Pathology biopsy report

0.00

0.0

1.0

—

(4146454)

0.00

0.0

2.6

—

(4268621)

0.00

0.0

2.6

—

(3029075) Extractable nuclear Ab panel - Serum

0.00

0.0

1.0

—

(3008757) Leukocyte morphology finding [Identifier] in Blood

0.00

0.0

4.1

—

(21494755) Public health laboratory ask at order entry panel

0.89

0.00

1.2

1.3

—

(3021601) Nitrite [Presence] in Urine by Test strip

320

1.00

0.00

5.2

5.1

0.00

estimate

—

(43055361) Metamyelocytes/Leukocytes [Pure number fraction] in Blood by Manual count

0.00

0.0

4.8

—

(3005570) Glucose [Moles/volume] in Urine

0.00

0.0

2.8

—

(42529200) Cancer Ag 15-3 [Units/volume] in Serum or Plasma by Immunoassay

0.00

0.0

3.7

—

14.24

—

(40764127) Haemophilus influenzae DNA [Presence] in Specimen by NAA with probe detection

0.00

0.0

1.5

—

(1617658) Protocol used for examination of sentinel lymph nodes

0.00

0.0

1.0

—

(3034603) RHD gene allele [Genotype] in Blood or Tissue by Molecular genetics method Nominal

0.00

0.0

1.2

—

(4027681)

0.00

0.0

1.2

—

(3016724) Homocysteine [Moles/volume] in Serum or Plasma

0.00

0.0

1.3

—

10.67

—

(21492711) Cytomegalovirus IgG Ab avidity [Presence] in Serum or Plasma by Immunoassay

0.00

0.0

1.1

—

(3024666) Lithium, Blood [Moles/volume] in Serum or Plasma

0.00

0.0

11.5

—

0.62

—

(3000034) Microalbumin [Mass/volume] in Urine

0.00

0.0

4.3

—

32.18

—

(3006588) Cancer Ag 15-3 [Units/volume] in Serum or Plasma

0.00

0.0

4.5

—

129.67

—

(40759844) Sjogrens syndrome-B extractable nuclear Ab [Presence] in Serum by Immunoblot

0.00

-0.00

0.0

1.3

—

(40759842) Ribonucleoprotein extractable nuclear Ab [Presence] in Serum by Immunoblot

0.00

-0.00

0.0

1.3

—

(40759843) Sjogrens syndrome-A extractable nuclear Ab [Presence] in Serum by Immunoblot

0.00

-0.00

0.0

1.3

—

(40759849) Smith extractable nuclear Ab [Presence] in Serum by Immunoblot

0.00

-0.00

0.0

1.3

—

(40759836) Histone Ab [Presence] in Serum by Immunoblot

0.00

-0.00

0.0

1.3

—

(3002523) Influenza virus A Ag [Presence] in Specimen

0.00

-0.00

0.0

1.0

—

(40759812) SCL-70 extractable nuclear Ab [Presence] in Serum by Immunoblot

0.00

-0.00

0.0

1.3

—

(40768795) Lymph node Pathology biopsy report

0.00

-0.00

0.0

1.0

—

(3043109) Cytology report of Tissue fine needle aspirate Cyto stain

0.00

-0.00

0.0

1.0

—

(4306422)

0.00

-0.00

0.0

1.4

—

Mortality – FinRegistry

↥

This endpoint is excluded from FinRegistry analyses (omitted endpoint).

Relationships between endpoints

↥

Index endpoint: VWXY20_EXPOS_EXCESSI_NATURAL_HEAT – Exposure to excessive natural heat

GWS hits: -

This endpoint is excluded from FinRegistry analyses (omitted endpoint).

≡ Risteys

FG R12 + FR

FinnGen R11 + FinRegistry

FinnGen R10 + FinRegistry

FinnGen R10

FinnGen R9

FinnGen R8

FinnGen R7

FinnGen R6

FinnGen R5

FinnGen R4

FinnGen R3

Exposure to excessive natural heat

Endpoint definition

Endpoint definition steps

FinnGen

Phenotype data

1. Apply sex-specific rule

2. Check conditions

3. Check pre-conditions, main-only, mode, registry filters

4. Check minimum number of events

5. Include endpoints

6. Filter based on genotype QC (FinnGen only)

All original rules

Similar endpoints

Case counts by codes

Upset plot

Case counts by code for Exposure to excessive natural heat (VWXY20_EXPOS_EXCESSI_NATURAL_HEAT)

Summary Statistics

-FinRegistry-

-FinnGen-

Key figures

-FinnGen-

Age distribution of first events

-FinnGen-

Year distribution of first events

-FinnGen-

Cumulative Incidence Function

CodeWAS (R11)

Matched cohort

LabWAS

Mortality – FinRegistry

Relationships between endpoints